Glycemic Targets and Prevention of Complications - Summary - MDSpire

Glycemic Targets and Prevention of Complications

  • By

  • Yumiko Tsushima

  • Nicholas Galloway

  • February 25, 2025

  • 0 min

Share

Objective:

To review glycemic targets, their evolution, and methods of screening and managing diabetes-related complications.

Key Findings:
  • Glycemic targets have evolved to focus on individualization and prevention of complications, including newer complications like CKM syndrome and MASLD.
  • HbA1c targets recommended are generally between 6.5% and 7% for most adults.
  • Intensive glycemic therapy has shown significant reductions in microvascular complications.
  • Evidence for glycemic targets reducing macrovascular complications is less definitive.
Interpretation:

Achieving glycemic targets and regular screening are crucial for preventing diabetes-related complications and managing disease progression.

Limitations:
  • The evidence for macrovascular complication reduction through glycemic control is not as robust, and there is a lack of consensus on specific targets.
  • Some studies were terminated early due to adverse outcomes, limiting conclusions.
Conclusion:

Maintaining glycemic targets, along with diligent screening and risk factor management, can effectively halt the progression of diabetes-related complications.

Original Source(s)

Glycemic Targets and Prevention of Complications

  • by Yumiko Tsushima, Nicholas Galloway

  • February 25, 2025

Related Content

Experts question diet guidelines' higher protein-intake advice

The Link Between Accelerated Biological Aging and the Inverse Relationship of Live Microbe Consumption with Diabetic Retinopathy in US Patients with Diabetes

Metformin’s Potential Role in PCO

Common diabetes therapy reaches intraocular lens tissue and may help limit posterior capsule opacification, says newly published data